Claviator-CV 500 mg+125 mg (Tablet)
Unit Price: ৳ 50.00 (1 x 7: ৳ 350.00)
Strip Price: ৳ 350.00
Medicine Details
Category | Details |
---|---|
Generic | Cefuroxime axetil clavulanic acid |
Company | Al madina pharmaceuticals ltd |
Also available as |
Title
- Claviator-CV 500 mg Tablet
Categories
- Medicine
- Antibiotic
- Infection Treatment
Description
- Claviator-CV 500 mg Tablet is an antibiotic indicated for the treatment of a variety of bacterial infections. It contains Cefuroxime, a second-generation cephalosporin antibiotic, and Clavulanic acid, a beta-lactamase inhibitor, in its formulation.
Dosage & Administration
- Recommended dosage for adolescents and adults (13 years and older) includes:
- Pharyngitis/Tonsillitis: 250 mg b.i.d. for 5-10 days
- Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days
- Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days
- Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days
- Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days
- Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days
- Uncomplicated Gonorrhoea: 1000 mg b.i.d. Single dose
- Community-acquired pneumonia: 250-500 mg b.i.d. for 5-10 days
- MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days
- Early Lyme disease: 500 mg b.i.d. for 20 days
- Pediatric dosage varies based on the specific condition being treated.
Indications
- Treatment of infections caused by sensitive bacteria including Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media, Acute bacterial maxillary sinusitis, Lower respiratory tract infections, Acute bacterial exacerbation of chronic bronchitis, Uncomplicated skin and skin-structure infections, Uncomplicated urinary tract infections, Bone and Joint Infections, Uncomplicated Gonorrhoea, Early Lyme Disease, Septicemia, Meningitis, Switch therapy (Injectable to oral).
Pharmacology
- Cefuroxime is a bactericidal second-generation cephalosporin antibiotic active against a wide range of Gram-positive and Gram-negative susceptible organisms.
- Clavulanic acid is a beta-lactamase inhibitor that protects Cefuroxime from degradation by beta-lactamase enzymes.
Interaction
- Concomitant administration of probenecid with Cefuroxime-Clavulanic Acid increases the area under the serum concentration versus time curve by 50%. Drug that reduces gastric acidity may result in a lower bioavailability of Cefuroxime.
Contraindications
- Cefuroxime-Clavulanic Acid is contraindicated in patients with known allergy to cephalosporin & in patients with Pseudomembranous Colitis.
Side Effects
- Common side effects include nausea, vomiting, diarrhea, abdominal discomfort or pain.
- Prolonged administration may result in overgrowth of non-susceptible microorganisms.
- Rare side effects include renal dysfunction, anaphylaxis, angioedema, pruritus, rash, and serum sickness-like urticaria.
Pregnancy & Lactation
- Cefuroxime-Clavulanic Acid can be safely used in later pregnancy to treat urinary and other infections.
- It is excreted into breast milk in small quantities.
Precautions & Warnings
- Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis.
Therapeutic Class
- Second-generation Cephalosporins
Storage Conditions
- Store in a cool, dry place (below 30°C), away from light and moisture. Keep out of the reach of children.
FAQs
- Claviator-CV 500 mg Tablet starts working within 2-3 hours after taking it.
- The effect of Claviator-CV 500 mg Tablet lasts for an average duration of 4-8 hours.
- Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
- No habit-forming tendencies were reported for Claviator-CV 500 mg Tablet.
Related Brands
- Cefaclav 125 mg+31.25 mg (Tablet) - incepta-pharmaceuticals-ltd
- Cefaclav 250 mg+62.5 mg (Tablet) - incepta-pharmaceuticals-ltd
- Cefaclav 500 mg+125 mg (Tablet) - incepta-pharmaceuticals-ltd
- Cefuxet Plus 500 mg+125 mg (Tablet) - chemist-laboratories-ltd
- Clavusef 125 mg+31.25 mg (Tablet) - opsonin-pharma-ltd